Overall rank by patents
#7,538
of 50,000 tracked assignees
USPTO PatentsView assignee record - 43 granted patents across 15 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
According to USPTO PatentsView, Carefusion ranks #7,538 of 50,000 tracked US assignees by granted-patent volume, with 43 patents across 15 technology areas.
Carefusion 207, Inc. has been granted 43 US utility patents between 2015 and 2019, placing Carefusion 207, Inc. at #7,538 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.5 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Carefusion 207, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Carefusion sits between Bracco Suisse Sa (43 patents, rank #7,533) and Carl Zeiss Jena Gmbh (43 patents, rank #7,541) - the closest US assignees by grant volume. The composite Innovation Score of 38.5/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 0 grants, compared with 43 in the 2015–2019 window, a -100% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Carefusion 207, Inc.'s 19.5 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 15 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Bracco Suisse SA
43 patents
Bruin Biometrics, LLC
43 patents
Buster and Punch Limited
43 patents
CALB Co., Ltd.
43 patents
CENTER FOR INTEGRATED SMART SENSORS FOUNDATION
43 patents
CHONGQING BOE DISPLAY TECHNOLOGY CO., LTD.
43 patents
Carbonite, Inc.
43 patents
Carl Zeiss Jena GmbH
43 patents
CAREFUSION 207, INC.
43 patents
What this shows Carefusion holds 43 patents at rank #7,537, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #7,537 in granted patent volume.
Other assignees with the most granted patents in Carefusion's primary technology class.
Carefusion's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
38 Top 41% higher than 59% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 21 | 48.8% |
| 2016 | 10 | 23.3% |
| 2017 | 4 | 9.3% |
| 2018 | 6 | 14.0% |
| 2019 | 2 | 4.7% |
Top 15 of 15 technology areas
Historical grant data only; it does not rate legal strength or current strategy.
Overall rank by patents
#7,538
of 50,000 tracked assignees
38.5 out of 100
How to use this portfolio
Carefusion's 43 grants land it in the top 41% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.